Susan dent

What a great Survivors Night with the @rocredwings! ⚾️ Thanks to everyone who joined us to help make this a wonderful celebration of the cancer survivors in our community ❤️🎗

Honoured to help celebrate cancer survivorship at the Wilmot Cancer Institute Survivorship night at the Rochester Red Wings baseball game! ⁦@ASCOPost⁩ ⁦@WilmotCancer⁩ ⁦@PlutaCancerFdn⁩ ⁦@ICOSociety⁩

Check out this recent paper on #InflammatoryBreastCancer, it examines the clinicogenomic characterization of #IBC. 👉pubmed.ncbi.nlm.nih.gov/40378057/ @npriedig @DrBBychkovsky @jenniferbellon2 @TariKingMD @DrEricWiner @lmsholl @stolaney1 @nlinmd @FilipaLynce @DrRBarroso…

Exercise is medicine. Physically active breast cancer survivors had 31% (95% CI: 25–37%) reduction in risk of breast cancer mortality relative to physically inactive pts. pmc.ncbi.nlm.nih.gov/articles/PMC12…

JCOG1017 trial found that primary tumor resection (PTR) did not prolong overall survival in de novo Stage IV breast cancer. However, it improved local control and might benefit subsets like premenopausal patients or those with single-organ metastasis. @JGbreast @TADSHIEN…

📢🧵Two back-to-back papers highlight a critical and overlooked issue in HR+/HER2– metastatic breast cancer (mBC): ⚠️cardiovascular comorbidities & QTc-risk meds are the norm, not exception. Here’s what we found & why it matters for oncologists + cardiologists👇@sdent_cardioonc…

Congrats Kuan & team! GLP1RA have been associated with ⬇️ mortality in cancer pts & even ⬇️ progression of MGUS to MM, this study shows it can ⬇️adverse CV outcomes & all cause mortality in pts with MGUS & diabetes @MichaelGNanna @knowingalok #cardioonc

Happy to me one of the #mascc25 social media ambassadors! See you soon Seattle!

#GCOS25 Abstracts proposals are due in one week! Submit your proposal by July 2nd to share your research in 🇿🇦 South Africa. Submit here: form.jotform.com/250751427992565 #cardioonc #cardiooncology #cancerresearch #oncology

Thanks you #ESCardiOnco2025 for allowing to share our experience in cardioprotection. @iLACOorg @escardio @ICOSociety @AsociacionArg @vanegrego @TeresaLpezFdez1 Diego Costa

Happy to share #ESCardioOnco2025 with leaders in cardio-oncology and to represent @ICOSociety @iLACOorg and @AsociacionArg around the world. @escardio @vanegrego @sdent_cardioon @Dr_Mike_Fradley

It was a privilege to participate in this panel discussion -how to establish a #cardiooncology program. Congratulations to @TeresaLpezFdez1 and #alexanderlyon on a great inaugural CO #ESC conference 👏🏼 @OncoAlert @OncBrothers #Oncology #Cardiology #MedTwitter @Dr_Mike_Fradley

Representing ICOS (President Dent and President elect Fradley)at the inaugural ESC cardio-oncology meeting in Florence - working together to improve cardiovascular health of patients with cancer ⁦@ICOSociety⁩ ⁦@OncoAlert⁩ ⁦@OncBrothers⁩ ⁦@CancerCareMASCC⁩

Great joint ICOS /ESC session at the inaugural ESC cardiology-oncology conference in Florence - how to establish a successful cardio-oncology program! ⁦@ICOSociety⁩ ⁦@escardio⁩

Dr Fradley stresses the importance of QT interval BUT we need to do a better job in measuring! ⁦@ICOSociety⁩ ⁦@escardio⁩

If #cardiotoxicity occurs during #chemotherapy, should we stop the treatment?🫀 Presented by Dr @DarrylLeong: ⚖️ Permissive cardiotoxicity balances effective #cancer therapy with #CVrisk management by: 📍Careful cardiac monitoring 📍Cardioprotective medications ➡️ ⚠️Limited…

@sdent_cardioonc @Dr_Mike_Fradley #ESCardioOnco2025 @ICOSociety

Who is considered a cancer survivor? Dr. Susan Dent (@sdent_cardioonc) leads our Judy DiMarzo Cancer Survivorship Program. She gives a definition and explains why this matters. Our Survivorship team is here to help! To learn more, call (585) 275-6956. #CancerSurvivorMonth

Great friends! Great memories #ESCardioOnco2025 @ICOSociety @escardio

Adds a touch of creativity to daily essentials. Get: niftyessence.com/holder